Screening novel sulfatase inhibitors for aggressive childhood Neuroblastoma
Predictive assessment of a novel image-based drug combination platform for childhood acute lymphoblastic leukaemia
Identifying sensitive biomarkers for the treatment of Medulloblastoma
Investigating the role of the MYCN-CDCA2 axis in neuroblastoma
Screening novel sulfatase inhibitors for aggressive childhood neuroblastoma
Using nanotechnology to find safer ways to treat childhood cancers
Investigating why some chemotherapies cause dangerous fluid build-up in the lungs of childhood cancer patients
Understanding why some chemotherapy drugs can lead to long-term damage to the hearts of childhood cancer patients
Identifying sensitive biomarkers for the treatment of Medulloblastoma
Exploring the use of Nanotechnology for targeted immunotherapy of Neuroblastoma
Finding new ways to identify treatment induced drug resistance in childhood leukaemia patients
Survival of cancer stem cells: a good opportunity in bad neighbourhood
0161 295 3864 